<p>Forest plot showing the achievement of SVR in CHC patients with low baseline HCV RNA treated with pegylated interferon α-2 plus ribavirin or pegylated interferon α-2 plus ribavirin plus a direct-acting antiviral.</p
<p>Forest plot showing the results of the final multivariate logistic regression analyses of factors...
BACKGROUND: To elucidate the benefits of successful antiviral therapy in chronic hepatitis C (CHC) p...
It is not clear what proportion of HCV (hepatitis C virus) patients attain a sustained viral respons...
<p>Forest plot showing the achievement of SVR in CHC patients with a rapid virological response trea...
<p>Forest plot showing the achievement of SVR in CHC patients without advanced liver fibrosis treate...
<p>Forest plot showing the achievement of SVR in CHC patients with genotype 1b treated with pegylate...
<p>Forest plot showing the achievement of SVR in CHC patients with the IL28-B CC haplotype treated w...
<p>Forest plot for the correlation of IL-28B rs12979860 with SVR in HCV-4 patients stratified by eth...
Background/Aims: Prediction of sustained virological response (SVR) during treatment would allow cli...
The goal of antiviral therapy for patients with chronic hepa-titis C virus (HCV) infection is to att...
Aim. The pool of HCV genotype 1 patients likely to be cured by peg-interferon and ribavirin re...
<p>SVR: sustained virological response; PR: pegylated interferon plus ribavirin; DAA: direct-acting ...
<p>Individual data of previously therapy-naive chronic HCV patients before, during and after therapy...
The ultimate goal of antiviral therapies for chronic HCV is to prevent progression of liver fibrosis...
<p>Abbreviations: SVR, sustained virological response; IRRDR[2a], interferon/ribavirin resistance-de...
<p>Forest plot showing the results of the final multivariate logistic regression analyses of factors...
BACKGROUND: To elucidate the benefits of successful antiviral therapy in chronic hepatitis C (CHC) p...
It is not clear what proportion of HCV (hepatitis C virus) patients attain a sustained viral respons...
<p>Forest plot showing the achievement of SVR in CHC patients with a rapid virological response trea...
<p>Forest plot showing the achievement of SVR in CHC patients without advanced liver fibrosis treate...
<p>Forest plot showing the achievement of SVR in CHC patients with genotype 1b treated with pegylate...
<p>Forest plot showing the achievement of SVR in CHC patients with the IL28-B CC haplotype treated w...
<p>Forest plot for the correlation of IL-28B rs12979860 with SVR in HCV-4 patients stratified by eth...
Background/Aims: Prediction of sustained virological response (SVR) during treatment would allow cli...
The goal of antiviral therapy for patients with chronic hepa-titis C virus (HCV) infection is to att...
Aim. The pool of HCV genotype 1 patients likely to be cured by peg-interferon and ribavirin re...
<p>SVR: sustained virological response; PR: pegylated interferon plus ribavirin; DAA: direct-acting ...
<p>Individual data of previously therapy-naive chronic HCV patients before, during and after therapy...
The ultimate goal of antiviral therapies for chronic HCV is to prevent progression of liver fibrosis...
<p>Abbreviations: SVR, sustained virological response; IRRDR[2a], interferon/ribavirin resistance-de...
<p>Forest plot showing the results of the final multivariate logistic regression analyses of factors...
BACKGROUND: To elucidate the benefits of successful antiviral therapy in chronic hepatitis C (CHC) p...
It is not clear what proportion of HCV (hepatitis C virus) patients attain a sustained viral respons...